VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $921,883 | -5.0% | 34,258 | +6.3% | 0.60% | -3.2% |
| Q2 2023 | $970,144 | -7.0% | 32,220 | -0.0% | 0.62% | -16.1% |
| Q1 2023 | $1,042,770 | +185.8% | 32,234 | +153.2% | 0.74% | +189.8% |
| Q4 2022 | $364,842 | -51.1% | 12,730 | -58.9% | 0.26% | -58.0% |
| Q3 2022 | $746,000 | -19.7% | 30,945 | -8.8% | 0.61% | -13.8% |
| Q2 2022 | $929,000 | -21.1% | 33,939 | +10.5% | 0.70% | -9.9% |
| Q1 2022 | $1,178,000 | -72.9% | 30,713 | -77.3% | 0.78% | -74.0% |
| Q4 2021 | $4,343,000 | -11.3% | 135,580 | -18.4% | 3.00% | -15.1% |
| Q3 2021 | $4,899,000 | -68.7% | 166,239 | -63.9% | 3.53% | -67.3% |
| Q2 2021 | $15,648,000 | +19.3% | 460,504 | +14.1% | 10.79% | +5.3% |
| Q1 2021 | $13,113,000 | – | 403,492 | – | 10.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |